Betamethasone Dipropionate
- Product NDC
- 0168-0267
- 11-digit product format
- 001680267
- Labeler code
- 0168
- Product ID
- 0168-0267_5d745268-8539-4108-a0eb-444a4b1424b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Betamethasone Dipropionate
- Dosage form
- LOTION, AUGMENTED
- Route
- TOPICAL
- Labeler
- E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
- Application
- ANDA077111
- Marketing category
- ANDA
- Marketing start
- 2007-05-21
- Substance
- BETAMETHASONE DIPROPIONATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Betamethasone Dipropionate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BETAMETHASONE DIPROPIONATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 826Y60901U |
| Rxcui | 848178 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 0168-0267-30 | 2022-07-01 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-60 | 2022-07-01 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-30 | 2021-07-23 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-60 | 2021-07-23 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-30 | 2020-09-18 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-60 | 2020-09-18 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-30 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
| 0168-0267-60 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-35ab-f274-e053-dbdaa90a6471 | These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05% safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE Lotion (Augmented), 0.05%. BETAMETHASONE DIPROPIONATE lotion (Augmented), 0.05% for topical use Initial U.S. Approval: 1983 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0168-0267-30 | Betamethasone Dipropionate | 30 mL in 1 BOTTLE | LOTION, AUGMENTED | 30 | | 13 |
| 0168-0267-60 | Betamethasone Dipropionate | 60 mL in 1 BOTTLE | LOTION, AUGMENTED | 60 | | 13 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BETAMETHASONE DIPROPIONATE | ACTIVE INGREDIENT | 826Y60901U | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| isopropyl alcohol | INACTIVE INGREDIENT | ND2M416302 | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| phosphoric acid | INACTIVE INGREDIENT | E4GA8884NN | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| sodium phosphate, monobasic | INACTIVE INGREDIENT | 3980JIH2SW | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 5 | |
| betamethasone dipropionate | ACTIVE INGREDIENT | 826Y60901U | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| betamethasone dipropionate | ACTIVE MOIETY | 826Y60901U | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| isopropyl alcohol | INACTIVE INGREDIENT | ND2M416302 | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| phosphoric acid | INACTIVE INGREDIENT | E4GA8884NN | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| sodium phosphate, monobasic | INACTIVE INGREDIENT | 3980JIH2SW | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | BETAMETHASONE DIPROPIONATE AUGMENTED (BETAMETHASONE DIPROPIONATE) LOTION [PHYSICIANS TOTAL CARE, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0168-0267 | BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20220702_4f411e41-00dc-47cf-8517-3ff5876e1bf5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0168-0267-30 | 00168026730 | 30 mL in 1 BOTTLE (0168-0267-30) | 30 ml | 2007-05-21 | 0000-00-00 | No | No | Current |
| 0168-0267-60 | 00168026760 | 60 mL in 1 BOTTLE (0168-0267-60) | 60 ml | 2007-05-21 | 0000-00-00 | No | No | Current |